Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 174

1.

Infusion of alloanergized donor lymphocytes after CD34-selected haploidentical myeloablative hematopoietic stem cell transplantation.

Davies JK, Brennan LL, Wingard J, Cogle CR, Kapoor N, Shah AJ, Dey BR, Spitzer TR, De Lima M, Cooper LJ, Thall P, Champlin RE, Nadler LM, Guinan EC.

Clin Cancer Res. 2018 May 16. pii: clincanres.0449.2018. doi: 10.1158/1078-0432.CCR-18-0449. [Epub ahead of print]

PMID:
29769208
2.

Phase I Trial of Brentuximab Vedotin for Steroid-Refractory Chronic Graft-Versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

DeFilipp Z, Li S, Kempner ME, Brown J, Del Rio C, Valles B, Hunnewell C, Saylor M, Vanderklish J, Dey BR, El-Jawahri A, McAfee SL, Spitzer TR, Chen YB.

Biol Blood Marrow Transplant. 2018 May 11. pii: S1083-8791(18)30264-7. doi: 10.1016/j.bbmt.2018.05.012. [Epub ahead of print]

PMID:
29758393
3.

Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.

DeFilipp Z, Peled JU, Li S, Mahabamunuge J, Dagher Z, Slingerland AE, Del Rio C, Valles B, Kempner ME, Smith M, Brown J, Dey BR, El-Jawahri A, McAfee SL, Spitzer TR, Ballen KK, Sung AD, Dalton TE, Messina JA, Dettmer K, Liebisch G, Oefner P, Taur Y, Pamer EG, Holler E, Mansour MK, van den Brink MRM, Hohmann E, Jenq RR, Chen YB.

Blood Adv. 2018 Apr 10;2(7):745-753. doi: 10.1182/bloodadvances.2018017731.

4.

Pilot study of a multimodal intervention to enhance sexual function in survivors of hematopoietic stem cell transplantation.

El-Jawahri A, Fishman SR, Vanderklish J, Dizon DS, Pensak N, Traeger L, Greer JA, Park ER, Markovitz N, Waldman L, Hunnewell C, Saylor M, Driscoll J, Li Z, Spitzer TR, McAfee S, Chen YB, Temel JS.

Cancer. 2018 Mar 14. doi: 10.1002/cncr.31333. [Epub ahead of print]

PMID:
29537491
5.

Autologous Stem Cell Transplantation in Elderly Lymphoma Patients in Their 70s: Outcomes and Analysis.

Sun L, Li S, El-Jawahri A, Armand P, Dey BR, Fisher DC, Jacobsen ED, Jacobson CA, LaCasce AS, McAfee SL, Spitzer TR, Chen YB, DeFilipp Z.

Oncologist. 2018 May;23(5):624-630. doi: 10.1634/theoncologist.2017-0499. Epub 2017 Dec 28.

PMID:
29284757
6.

Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.

Sasaki H, Oura T, Spitzer TR, Chen YB, Madsen JC, Allan J, Sachs DH, Cosimi AB, Kawai T.

Hum Immunol. 2018 May;79(5):258-265. doi: 10.1016/j.humimm.2017.11.008. Epub 2017 Nov 22. Review.

PMID:
29175110
7.

Neurologic complications after allogeneic hematopoietic stem cell transplantation: risk factors and impact.

Dowling MR, Li S, Dey BR, McAfee SL, Hock HR, Spitzer TR, Chen YB, Ballen KK.

Bone Marrow Transplant. 2018 Feb;53(2):199-206. doi: 10.1038/bmt.2017.239. Epub 2017 Nov 13.

PMID:
29131150
8.

Hematopoietic stem cell transplant-associated thrombotic microangiopathy: current paradigm and novel therapies.

Khosla J, Yeh AC, Spitzer TR, Dey BR.

Bone Marrow Transplant. 2018 Feb;53(2):129-137. doi: 10.1038/bmt.2017.207. Epub 2017 Oct 2. Review.

PMID:
28967899
9.

Effect of Inpatient Palliative Care During Hematopoietic Stem-Cell Transplant on Psychological Distress 6 Months After Transplant: Results of a Randomized Clinical Trial.

El-Jawahri A, Traeger L, Greer JA, VanDusen H, Fishman SR, LeBlanc TW, Pirl WF, Jackson VA, Telles J, Rhodes A, Li Z, Spitzer TR, McAfee S, Chen YA, Temel JS.

J Clin Oncol. 2017 Nov 10;35(32):3714-3721. doi: 10.1200/JCO.2017.73.2800. Epub 2017 Sep 19.

PMID:
28926288
10.

Preoperative autologous blood donation in healthy bone marrow donors contributes to pre-procedure anemia.

Manuel SP, Spitzer TR, Ishizawa Y.

Bone Marrow Transplant. 2017 Aug;52(8):1191-1193. doi: 10.1038/bmt.2017.84. Epub 2017 May 22. No abstract available.

PMID:
28530672
11.

Transfusion practices for bone marrow harvests: a survey analysis from the AABB Bone Marrow Quality Improvement Initiative Working Group.

Spitzer TR, Sugrue MW, Gonzalez C, O'Donnell P, Confer D, Fuchs E, Pulsipher MA, Schwartz J, Linenberger M.

Bone Marrow Transplant. 2017 Aug;52(8):1199-1200. doi: 10.1038/bmt.2017.92. Epub 2017 May 22. No abstract available.

PMID:
28530670
12.

Phase 1 multicenter trial of brentuximab vedotin for steroid-refractory acute graft-versus-host disease.

Chen YB, Perales MA, Li S, Kempner M, Reynolds C, Brown J, Efebera YA, Devine SM, El-Jawahri A, McAfee SL, Spitzer TR, Soiffer RJ, Ritz J, Cutler C.

Blood. 2017 Jun 15;129(24):3256-3261. doi: 10.1182/blood-2017-03-772210. Epub 2017 May 4.

PMID:
28473406
13.

GvHD after umbilical cord blood transplantation for acute leukemia: an analysis of risk factors and effect on outcomes.

Chen YB, Wang T, Hemmer MT, Brady C, Couriel DR, Alousi A, Pidala J, Urbano-Ispizua A, Choi SW, Nishihori T, Teshima T, Inamoto Y, Wirk B, Marks DI, Abdel-Azim H, Lehmann L, Yu L, Bitan M, Cairo MS, Qayed M, Salit R, Gale RP, Martino R, Jaglowski S, Bajel A, Savani B, Frangoul H, Lewis ID, Storek J, Askar M, Kharfan-Dabaja MA, Aljurf M, Ringden O, Reshef R, Olsson RF, Hashmi S, Seo S, Spitzer TR, MacMillan ML, Lazaryan A, Spellman SR, Arora M, Cutler CS.

Bone Marrow Transplant. 2017 Mar;52(3):400-408. doi: 10.1038/bmt.2016.265. Epub 2016 Dec 12.

14.

Effect of Inpatient Palliative Care on Quality of Life 2 Weeks After Hematopoietic Stem Cell Transplantation: A Randomized Clinical Trial.

El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, Jackson VA, Telles J, Rhodes A, Spitzer TR, McAfee S, Chen YA, Lee SS, Temel JS.

JAMA. 2016 Nov 22;316(20):2094-2103. doi: 10.1001/jama.2016.16786.

15.

Haematopoietic cell transplantation with and without sorafenib maintenance for patients with FLT3-ITD acute myeloid leukaemia in first complete remission.

Brunner AM, Li S, Fathi AT, Wadleigh M, Ho VT, Collier K, Connolly C, Ballen KK, Cutler CS, Dey BR, El-Jawahri A, Nikiforow S, McAfee SL, Koreth J, Deangelo DJ, Alyea EP, Antin JH, Spitzer TR, Stone RM, Soiffer RJ, Chen YB.

Br J Haematol. 2016 Nov;175(3):496-504. doi: 10.1111/bjh.14260. Epub 2016 Jul 19.

16.

Donor Lymphocyte Infusion-Mediated Graft-versus-Host Responses in a Preclinical Swine Model of Haploidentical Hematopoietic Cell Transplantation.

Duran-Struuck R, Matar AJ, Crepeau RL, Teague AGS, Horner BM, Pathiraja V, Spitzer TR, Fishman JA, Bronson RT, Sachs DH, Huang CA.

Biol Blood Marrow Transplant. 2016 Nov;22(11):1953-1960. doi: 10.1016/j.bbmt.2016.08.011. Epub 2016 Aug 16.

17.

Combined Bone Marrow and Kidney Transplantation for the Induction of Specific Tolerance.

Chen YB, Kawai T, Spitzer TR.

Adv Hematol. 2016;2016:6471901. doi: 10.1155/2016/6471901. Epub 2016 Apr 30. Review.

18.

Improved Treatment-Related Mortality and Overall Survival of Patients with Grade IV Acute GVHD in the Modern Years.

El-Jawahri A, Li S, Antin JH, Spitzer TR, Armand PA, Koreth J, Nikiforow S, Ballen KK, Ho VT, Alyea EP, Dey BR, McAfee SL, Glotzbecker BE, Soiffer RJ, Cutler CS, Chen YB.

Biol Blood Marrow Transplant. 2016 May;22(5):910-8. doi: 10.1016/j.bbmt.2015.12.024. Epub 2015 Dec 31.

19.

Quality of life and mood predict posttraumatic stress disorder after hematopoietic stem cell transplantation.

El-Jawahri AR, Vandusen HB, Traeger LN, Fishbein JN, Keenan T, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Spitzer TR, Chen YB, Temel JS.

Cancer. 2016 Mar 1;122(5):806-12. doi: 10.1002/cncr.29818. Epub 2015 Dec 9.

20.

Miniature Swine as a Clinically Relevant Model of Graft-Versus-Host Disease.

Duran-Struuck R, Huang CA, Orf K, Bronson RT, Sachs DH, Spitzer TR.

Comp Med. 2015 Oct;65(5):429-43. Review.

21.

Intersection of Hematopoietic Cell and Solid Organ Transplantation: Lessons Learned and Unanswered Questions.

Spitzer TR.

Biol Blood Marrow Transplant. 2015 Dec;21(12):2037-2038. doi: 10.1016/j.bbmt.2015.10.003. Epub 2015 Oct 14. No abstract available.

22.

Phase II Trial of Reduced-Intensity Busulfan/Clofarabine Conditioning with Allogeneic Hematopoietic Stem Cell Transplantation for Patients with Acute Myeloid Leukemia, Myelodysplastic Syndromes, and Acute Lymphoid Leukemia.

El-Jawahri A, Li S, Ballen KK, Cutler C, Dey BR, Driscoll J, Hunnewell C, Ho VT, McAfee SL, Poliquin C, Saylor M, Soiffer RJ, Spitzer TR, Alyea E, Chen YB.

Biol Blood Marrow Transplant. 2016 Jan;22(1):80-5. doi: 10.1016/j.bbmt.2015.08.001. Epub 2015 Aug 7.

23.

Phase II Trial of Tandem High-Dose Chemotherapy with Autologous Stem Cell Transplantation Followed by Reduced-Intensity Allogeneic Stem Cell Transplantation for Patients with High-Risk Lymphoma.

Chen YB, Li S, Fisher DC, Driscoll J, Del Rio C, Abramson J, Armand P, Barnes J, Brown J, Cutler C, El-Jawahri A, Ho VT, Hochberg E, McAfee S, Takvorian R, Spitzer TR, Antin JH, Soiffer R, Jacobsen E.

Biol Blood Marrow Transplant. 2015 Sep;21(9):1583-8. doi: 10.1016/j.bbmt.2015.05.016. Epub 2015 May 22.

24.

Prognostic understanding, quality of life and mood in patients undergoing hematopoietic stem cell transplantation.

El-Jawahri A, Traeger L, Kuzmuk K, Eusebio J, Vandusen H, Keenan T, Shin J, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Ballen KK, Spitzer TR, Graubert TA, McAfee S, Dey B, Chen YB, Temel JS.

Bone Marrow Transplant. 2015 Aug;50(8):1119-24. doi: 10.1038/bmt.2015.113. Epub 2015 May 11.

25.

Difficulties in hematopoietic progenitor cell collection from a patient with TEMPI syndrome and severe iatrogenic iron deficiency.

Belizaire R, Sykes DB, Chen YB, Spitzer TR, Makar RS.

Transfusion. 2015 Sep;55(9):2142-8. doi: 10.1111/trf.13125. Epub 2015 Apr 24.

PMID:
25911963
26.

Engraftment syndrome: double-edged sword of hematopoietic cell transplants.

Spitzer TR.

Bone Marrow Transplant. 2015 Apr;50(4):469-75. doi: 10.1038/bmt.2014.296. Epub 2015 Jan 12. Review.

PMID:
25581406
27.

Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation.

El-Jawahri AR, Traeger LN, Kuzmuk K, Eusebio JR, Vandusen HB, Shin JA, Keenan T, Gallagher ER, Greer JA, Pirl WF, Jackson VA, Ballen KK, Spitzer TR, Graubert TA, McAfee SL, Dey BR, Chen YB, Temel JS.

Cancer. 2015 Mar 15;121(6):951-9. doi: 10.1002/cncr.29149. Epub 2014 Dec 2.

28.

Phase I trial of maintenance sorafenib after allogeneic hematopoietic stem cell transplantation for fms-like tyrosine kinase 3 internal tandem duplication acute myeloid leukemia.

Chen YB, Li S, Lane AA, Connolly C, Del Rio C, Valles B, Curtis M, Ballen K, Cutler C, Dey BR, El-Jawahri A, Fathi AT, Ho VT, Joyce A, McAfee S, Rudek M, Rajkhowa T, Verselis S, Antin JH, Spitzer TR, Levis M, Soiffer R.

Biol Blood Marrow Transplant. 2014 Dec;20(12):2042-8. doi: 10.1016/j.bbmt.2014.09.007. Epub 2014 Sep 17.

29.

Phase 2 trial of high-dose rituximab with high-dose cytarabine mobilization therapy and high-dose thiotepa, busulfan, and cyclophosphamide autologous stem cell transplantation in patients with central nervous system involvement by non-Hodgkin lymphoma.

Chen YB, Batchelor T, Li S, Hochberg E, Brezina M, Jones S, Del Rio C, Curtis M, Ballen KK, Barnes J, Chi AS, Dietrich J, Driscoll J, Gertsner ER, Hochberg F, LaCasce AS, McAfee SL, Spitzer TR, Nayak L, Armand P.

Cancer. 2015 Jan 15;121(2):226-33. doi: 10.1002/cncr.29023. Epub 2014 Sep 9.

30.

Outcomes and management strategies for graft failure after umbilical cord blood transplantation.

Singh H, Nikiforow S, Li S, Ballen KK, Spitzer TR, Soiffer R, Antin JH, Cutler C, Chen YB.

Am J Hematol. 2014 Dec;89(12):1097-101. doi: 10.1002/ajh.23845. Epub 2014 Sep 26.

31.

Improved survival after transplantation of more donor plasmacytoid dendritic or naïve T cells from unrelated-donor marrow grafts: results from BMTCTN 0201.

Waller EK, Logan BR, Harris WA, Devine SM, Porter DL, Mineishi S, McCarty JM, Gonzalez CE, Spitzer TR, Krijanovski OI, Linenberger ML, Woolfrey A, Howard A, Wu J, Confer DL, Anasetti C.

J Clin Oncol. 2014 Aug 1;32(22):2365-72. doi: 10.1200/JCO.2013.54.4577. Epub 2014 Jun 30.

32.

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW Jr, Smith RN, Colvin RB, Sykes M, Cosimi AB.

Am J Transplant. 2014 Jul;14(7):1599-611. doi: 10.1111/ajt.12731. Epub 2014 Jun 5.

33.

Engraftment syndrome after allogeneic hematopoietic cell transplantation in adults.

Omer AK, Kim HT, Yalamarti B, McAfee SL, Dey BR, Ballen KK, Attar E, Chen YB, Spitzer TR.

Am J Hematol. 2014 Jul;89(7):698-705. doi: 10.1002/ajh.23716. Epub 2014 Apr 10.

34.

Phase I study of urate oxidase in the reduction of acute graft-versus-host disease after myeloablative allogeneic stem cell transplantation.

Yeh AC, Brunner AM, Spitzer TR, Chen YB, Coughlin E, McAfee S, Ballen K, Attar E, Caron M, Preffer FI, Yeap BY, Dey BR.

Biol Blood Marrow Transplant. 2014 May;20(5):730-4. doi: 10.1016/j.bbmt.2014.02.003. Epub 2014 Feb 12.

35.

Outcomes in patients age 70 or older undergoing allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Brunner AM, Kim HT, Coughlin E, Alyea EP 3rd, Armand P, Ballen KK, Cutler C, Dey BR, Glotzbecker B, Koreth J, McAfee SL, Spitzer TR, Soiffer RJ, Antin JH, Ho VT, Chen YB.

Biol Blood Marrow Transplant. 2013 Sep;19(9):1374-80. doi: 10.1016/j.bbmt.2013.06.008. Epub 2013 Jun 18.

36.

Risk factors for invasive fungal disease after allogeneic hematopoietic stem cell transplantation: a single center experience.

Omer AK, Ziakas PD, Anagnostou T, Coughlin E, Kourkoumpetis T, McAfee SL, Dey BR, Attar E, Chen YB, Spitzer TR, Mylonakis E, Ballen KK.

Biol Blood Marrow Transplant. 2013 Aug;19(8):1190-6. doi: 10.1016/j.bbmt.2013.05.018. Epub 2013 Jun 5.

37.

Busulfan dose intensity and outcomes in reduced-intensity allogeneic peripheral blood stem cell transplantation for myelodysplastic syndrome or acute myeloid leukemia.

Chen YB, Coughlin E, Kennedy KF, Alyea EP, Armand P, Attar EC, Ballen KK, Cutler C, Dey BR, Koreth J, McAfee SL, Spitzer TR, Antin JH, Soiffer RJ, Ho VT.

Biol Blood Marrow Transplant. 2013 Jun;19(6):981-7. doi: 10.1016/j.bbmt.2013.03.016. Epub 2013 Apr 2.

38.

Chronic graft-versus-host disease with skin signs suspicious for squamous cell carcinoma.

El-Rayess HM, Refaat MM, Post MD, Spitzer TR, Dey B.

Acta Oncol. 2013 Aug;52(6):1213-4. doi: 10.3109/0284186X.2012.734923. Epub 2012 Dec 3. No abstract available.

PMID:
23198720
39.

Microtransplantation: a new paradigm for the separation of graft versus host disease and graft versus tumor?

Spitzer TR.

J Clin Oncol. 2012 Nov 20;30(33):4051-2. doi: 10.1200/JCO.2012.45.2979. Epub 2012 Oct 8. No abstract available.

PMID:
23045583
40.

Edema and tetraparesis in a miniature pig after allogeneic hematopoietic cell transplantation.

Crepeau R, Matar A, Spitzer TR, Robson S, Pathiraja V, Sachs DH, Huang CA, Duran-Struuck R.

Comp Med. 2012 Aug;62(4):298-302.

41.

Expression of α4β7 integrin on memory CD8(+) T cells at the presentation of acute intestinal GVHD.

Chen YB, McDonough S, Chen H, Kennedy J, Illiano C, Attar EC, Ballen KK, Dey BR, McAfee SL, Jagasia M, Soiffer R, Spitzer TR, Ritz J.

Bone Marrow Transplant. 2013 Apr;48(4):598-603. doi: 10.1038/bmt.2012.191. Epub 2012 Oct 8.

PMID:
23042495
42.

Lack of antidonor alloantibody does not indicate lack of immune sensitization: studies of graft loss in a haploidentical hematopoietic cell transplantation swine model.

Duran-Struuck R, Matar A, Crepeau R, Gusha A, Schenk M, Hanekamp I, Pathiraja V, Spitzer TR, Sachs DH, Huang CA.

Biol Blood Marrow Transplant. 2012 Nov;18(11):1629-37. doi: 10.1016/j.bbmt.2012.08.004. Epub 2012 Aug 11.

43.

The expanding frontier of hematopoietic cell transplantation.

Spitzer TR, Dey BR, Chen YB, Attar E, Ballen KK.

Cytometry B Clin Cytom. 2012 Sep;82(5):271-9. doi: 10.1002/cyto.b.21034. Epub 2012 Aug 3. Review.

44.

Phase II trial of parathyroid hormone after double umbilical cord blood transplantation.

Ballen K, Mendizabal AM, Cutler C, Politikos I, Jamieson K, Shpall EJ, Dey BR, Attar E, McAfee S, Delaney C, McCarthy P, Ball ED, Kamble R, Avigan D, Maziarz RT, Ho VT, Koreth J, Alyea E, Soiffer R, Wingard JR, Boussiotis V, Spitzer TR, Antin JH.

Biol Blood Marrow Transplant. 2012 Dec;18(12):1851-8. doi: 10.1016/j.bbmt.2012.06.016. Epub 2012 Jul 2.

45.

Expression of CD30 in patients with acute graft-versus-host disease.

Chen YB, McDonough S, Hasserjian R, Chen H, Coughlin E, Illiano C, Park IS, Jagasia M, Spitzer TR, Cutler CS, Soiffer RJ, Ritz J.

Blood. 2012 Jul 19;120(3):691-6. doi: 10.1182/blood-2012-03-415422. Epub 2012 Jun 1.

46.

Changing stripes to avoid graft versus leukemia.

Spitzer TR.

Transplantation. 2012 Apr 15;93(7):674-5. doi: 10.1097/TP.0b013e3182481154. No abstract available.

PMID:
22456485
47.

A model for personalized in vivo analysis of human immune responsiveness.

Kalscheuer H, Danzl N, Onoe T, Faust T, Winchester R, Goland R, Greenberg E, Spitzer TR, Savage DG, Tahara H, Choi G, Yang YG, Sykes M.

Sci Transl Med. 2012 Mar 14;4(125):125ra30. doi: 10.1126/scitranslmed.3003481.

48.

Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant.

Ballen KK, Koreth J, Chen YB, Dey BR, Spitzer TR.

Blood. 2012 Mar 1;119(9):1972-80. doi: 10.1182/blood-2011-11-354563. Epub 2011 Dec 30. Review.

49.

Effects of mobilization regimens in donors on outcomes of hematopoietic cell transplantation in miniature Swine.

Matar AJ, Crepeau RL, Pathiraja V, Robson S, Fishman JA, Spitzer TR, Sachs DH, Huang CA, Duran-Struuck R.

Comp Med. 2012 Dec;62(6):487-94.

50.

Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant.

Lane AA, Armand P, Feng Y, Neuberg DS, Abramson JS, Brown JR, Fisher DC, LaCasce AS, Jacobsen ED, McAfee SL, Spitzer TR, Freedman AS, Chen YB.

Leuk Lymphoma. 2012 Jun;53(6):1130-6. doi: 10.3109/10428194.2011.645208. Epub 2012 Jan 3.

Supplemental Content

Loading ...
Support Center